Every Life Sciences event discusses digitilization. How do you choose between investing in digitizing new products for customers and developing digital solutions for effective and innovative clinical trials? A completely different objective, different users, and different insights. That’s not all. Potential revenues differ significantly and the risk isn’t comparable. Is creating a specific application to gain user insights in trials even worth the money? In this session with Cochlear, Tom Bertens, Director Research Algorithms & Applications at Cochlear, and Laurent Schauvlieghe, Manager Innovation Acceleration at Verhaert Digital, will give you some inspiration on how to tackle this paradox.
Watch the recording
